Trial intelligence / Profile preview

NPY for Major Depressive Disorder

2014-000129-19Phase 2Terminated

Sponsor
Karolinska University Hospital
Start
Mar 2014
Modality
Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing NPY with Placebo (2 arms). Started Mar 2014; status: terminated.

02

Drugs

neuropeptide Y (1-36)
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on 2014-000129-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000129-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call